MedTrace Logo

Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)

NCT00211705 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 8000

Last updated 2006-12-04

No results posted yet for this study

Summary

To evaluate the primary preventive effect of low-dose pravastatin against coronary heart disease (CHD) in Japanese hypercholesterolemic patients.

Conditions

Interventions

BEHAVIORAL

Diet

DRUG

Diet+pravastatin

Sponsors & Collaborators

  • Daiichi Sankyo Co., Ltd.

    collaborator INDUSTRY

  • Ministry of Health, Labour and Welfare, Japan

    collaborator OTHER_GOV

  • Mitsukoshi Health and Welfare Foundation

    lead INDUSTRY

Principal Investigators

  • Haruo Nakamura, MD · Mitsukoshi Health and Welfare

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-02-28
Completion
2004-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00211705 on ClinicalTrials.gov